Loss of temporal retinal nerve fibers in Parkinson disease: A mitochondrial pattern?

European Journal of Neurology

Volumn 20, Issue 1, 2013, Pages 198-201

  La Morgia, C ^a,b   Barboni, P ^b   Rizzo, G ^a,b   Carbonelli, M ^c   Savini, G ^c   Scaglione, C ^a,b   Capellari, S ^a,b   Bonazza, S ^a,b   Giannoccaro, M P ^a,b   Calandra Buonaura, G ^a,b   Liguori, R ^a,b   Cortelli, P ^a,b   Martinelli, P ^a,b   Baruzzi, A ^a,b   Carelli, V ^a,b  

^a IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Mitochondrial disorders; Optic nerve; Optical coherence tomography; Parkinson's disease; Retina

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; MALE; MITOCHONDRION; OPTICAL COHERENCE TOMOGRAPHY; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA DISEASE; RETINAL NERVE FIBER LAYER THICKNESS; TEMPORAL RETINAL NERVE FIBER LOSS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE FIBERS; OPTIC NERVE; OPTIC NERVE DISEASES; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84871670208     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03701.x     Document Type: Article

References (18)

1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5: 525-535.
2. Simuni T, Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008; 64: S65-S80.
3. Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 2008; 7: 97-109.
4. Whitworth AJ, Pallanck LJ. The PINK1/Parkin pathway: a mitochondrial quality control system?J Bioenerg Biomembr 2009; 41: 499-503.
5. Carelli V, La Morgia C, Valentino ML, Barboni P, Ross-Cisneros FN, Sadun AA. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim Biophys Acta 2009; 1787: 518-528.
6. Barboni P, Savini G, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 2005; 112: 120-126.
7. Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology 2010; 117: 623-627.
8. Bodis-Wollner I. Retinopathy in Parkinson Disease. J Neural Transm 2009; 116: 1493-1501.
9. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res 2004; 44: 2793-2797.
10. Yavas GF, Yilmaz O, Küsbeci T, Oztürk F. The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease. Eur J Ophthalmol 2007; 17: 812-816.
11. Altintaş O, Işeri P, Ozkan B, Caǧlar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol 2008; 116: 137-146.
12. Hajee ME, March WF, Lazzaro DR, et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009; 127: 737-741.
13. Moschos MM, Tagaris G, Markopoulos I, et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 2011; 21: 24-29.
14. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 431-436.
15. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
16. Zucco G, Zeni MT, Perrone A, Piccolo I. Olfactory sensitivity in early-stage Parkinson patients affected by more marked unilateral disorder. Percept Mot Skills 2001; 92: 894-898.
17. White KE, Davies VJ, Hogan VE, et al. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. Invest Ophthalmol Vis Sci 2009; 50: 2567-2571.
18. Vives-Bauza C, Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol Med 2011; 17: 158-165.